News Articles Tagged: TGF-beta Signaling Pathway

Unlocking Cancer Therapies: The Role of TGF-β Receptor Inhibitors

Explore how TGF-β receptor inhibitors like Galunisertib (CAS 700874-72-2) are revolutionizing cancer research and immunotherapy. Learn from a leading manufacturer.

Understanding SB525334: A Key Pharmaceutical Intermediate for Fibrosis Research

Explore the advanced pharmaceutical intermediate SB525334 (CAS 356559-20-1). Learn about its role as a TGF-β Receptor I inhibitor and its applications in combating fibrosis. Purchase from a trusted supplier.